Literature DB >> 11093410

Atrial fibrillation: the most common arrhythmia.

C R Wyndham1.   

Abstract

Atrial fibrillation is the most common sustained arrhythmia, increases with age, and presents with a wide spectrum of symptoms and severity Paroxysmal, persistent, and permanent forms require very individualized approaches to management. New information about electrical and anatomic remodeling emphasizes the importance of time-related thrombogenicity and progressive interference with mechanical function of the atria and ventricles. The most important aspect of diagnosis is risk stratification with respect to risk of thromboembolism. The general goals in treatment are, in order of importance: prevention of thromboemboli, control of ventricular response, restoration of sinus rhythm, and maintenance of sinus rhythm by preventing recurrences. This review focuses on the above issues. The therapeutic choices are discussed under each category Antiarrhythmic drugs, radiofrequency ablation techniques, and device therapy are reviewed with respect to prevention of recurrent atrial fibrillation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093410      PMCID: PMC101077     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  44 in total

1.  High-density mapping of activation through an incomplete isthmus ablation line.

Authors:  D Shah; M Haïssaguerre; P Jaïs; A Takahashi; M Hocini; J Clémenty
Journal:  Circulation       Date:  1999-01-19       Impact factor: 29.690

Review 2.  Atrial electrophysiologic remodeling: another vicious circle?

Authors:  M A Allessie
Journal:  J Cardiovasc Electrophysiol       Date:  1998-12

3.  Uncommon atrial flutter: characteristics, mechanisms, and results of ablative therapy.

Authors:  J A Gomes; F Santoni-Rugiu; D Mehta; N M Langan; S O Marx; H Nayak
Journal:  Pacing Clin Electrophysiol       Date:  1998-11       Impact factor: 1.976

4.  Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation.

Authors:  L Yue; P Melnyk; R Gaspo; Z Wang; S Nattel
Journal:  Circ Res       Date:  1999-04-16       Impact factor: 17.367

5.  Interatrial septum pacing: a new approach to prevent recurrent atrial fibrillation.

Authors:  L Padeletti; M C Porciani; A Michelucci; A Colella; P Ticci; S Vena; A Costoli; C Ciapetti; P Pieragnoli; G F Gensini
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

6.  Right atrial compartmentalization using radiofrequency catheter ablation for management of patients with refractory atrial fibrillation.

Authors:  A Garg; W Finneran; M Mollerus; U Birgersdotter-Green; O Fujimura; L Tone; G K Feld
Journal:  J Cardiovasc Electrophysiol       Date:  1999-06

7.  Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation.

Authors:  H F Tse; C P Lau; C M Yu; K L Lee; G F Michaud; B P Knight; F Morady; S A Strickberger
Journal:  J Cardiovasc Electrophysiol       Date:  1999-09

8.  Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation.

Authors:  P Jaïs; D C Shah; A Takahashi; M Hocini; M Haïssaguerre; J Clémenty
Journal:  Pacing Clin Electrophysiol       Date:  1998-11       Impact factor: 1.976

9.  Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators.

Authors:  S M Fitts; M R Hill; R Mehra; P Friedman; S Hammill; G N Kay; A Prakash; C Webb; S Saksena
Journal:  J Interv Card Electrophysiol       Date:  1998-06       Impact factor: 1.900

10.  Radiofrequency catheter ablation of common atrial flutter: significance of palpitations and quality-of-life evaluation in patients with proven isthmus block.

Authors:  F Anselme; N Saoudi; H Poty; R Douillet; A Cribier
Journal:  Circulation       Date:  1999-02-02       Impact factor: 29.690

View more
  36 in total

1.  A novel approach to the prevention of thromboembolism in atrial fibrillation.

Authors:  A K Ganjoo
Journal:  Tex Heart Inst J       Date:  2001

2.  The cognitive impact of atrial fibrillation.

Authors:  Anne F Gross; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2013-01-10

Review 3.  Catheter-based ablation of atrial fibrillation: a brief overview.

Authors:  Leila Ganjehei; Mehdi Razavi; Abdi Rasekh
Journal:  Tex Heart Inst J       Date:  2011

Review 4.  Exclusion of the left atrial appendage to prevent stroke in cases of atrial fibrillation.

Authors:  Armin Barekatain; Abdi Rasekh; Ali Massumi
Journal:  Tex Heart Inst J       Date:  2012

Review 5.  Neuro-atriomyodegenerative origin of atrial fibrillation and superimposed conventional risk factors: continued search to configure the genuine etiology of "eternal arrhythmia".

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2016-12-31

Review 6.  Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: Mechanisms and model systems.

Authors:  Jason Pellman; Jing Zhang; Farah Sheikh
Journal:  J Mol Cell Cardiol       Date:  2016-03-18       Impact factor: 5.000

Review 7.  Postoperative atrial fibrillation in patients undergoing non-cardiac non-thoracic surgery: A practical approach for the hospitalist.

Authors:  Kirti K Joshi; Mihaela Tiru; Thomas Chin; Marshal T Fox; Mihaela S Stefan
Journal:  Hosp Pract (1995)       Date:  2015

Review 8.  Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.

Authors:  Pattara Rattanawong; Sikarin Upala; Tanawan Riangwiwat; Veeravich Jaruvongvanich; Anawin Sanguankeo; Wasawat Vutthikraivit; Eugene H Chung
Journal:  J Interv Card Electrophysiol       Date:  2018-01-13       Impact factor: 1.900

9.  Atrial Fibrillation and Atrial Flutter Ablation - an Unconventional Approach.

Authors:  Siddiqui R Usman; Buciuc G Adela; Krishnan Suraj
Journal:  J Atr Fibrillation       Date:  2019-06-30

10.  Sample Entropy in Electrocardiogram During Atrial Fibrillation.

Authors:  Takuya Horie; Naoto Burioka; Takashi Amisaki; Eiji Shimizu
Journal:  Yonago Acta Med       Date:  2018-03-28       Impact factor: 1.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.